ELCC: Urine tumor DNA shows high testing promise

GENEVA – Blood sampling provides a less invasive alternative to tumor biopsy for collecting cancer DNA for mutation testing, but retrieving tumor DN... More »

Field of Interest: Oncology
Type: News Item

New agent targets EGFR resistance in NSCLC

A new agent targeting tumors that develop resistance to EGFR tyrosine kinase inhibitors proved to be “highly active” in a phase I clinical trial i... More »

Field of Interest: Oncology
Type: News Item

Rociletinib active against resistant NSCLC

Rociletinib, a third-generation EGFR tyrosine kinase inhibitor that targets mutations causing treatment resistance, showed sustained activity against ... More »

Field of Interest: Oncology
Type: News Item

AACR: Biomarker of response to olaparib found

A phase II study evaluating single-agent olaparib in metastatic, castration-resistant prostate cancer offers the first evidence that genetic testing c... More »

Field of Interest: Oncology
Type: News Item

Nitric oxide treatment works for genital warts

The coapplication of two topical creams, one containing 6% sodium nitrite and another containing 9% citric acid, together producing nitric oxide, was ... More »

Field of Interest: Dermatology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness